Evidence map›Paper›PMID 36296939›Full record

Trial reportNutrients2022

Effects of Dietary Supplementation with Carrot-Derived Rhamnogalacturonan-I (cRG-I) on Accelerated Protective Immune Responses and Quality of Life in Healthy Volunteers Challenged with Rhinovirus in a Randomized Trial.

Sue McKay, Annemarie Teitsma-Jansen, Esther Floris, Tamara Dekker, Barbara Smids, Ridha Khurshid, Wim Calame, Alwine Kardinaal, René Lutter, Ruud Albers

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sue McKayNutriLeads B.V., Bronland 12-N, 6708 WH Wageningen, The Netherlands.
Annemarie Teitsma-JansenAmsterdam UMC, Department of Experimental Immunology, University of Amsterdam and Amsterdam Infection & Immunity Institute, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Esther FlorisNIZO, Kernhemseweg 2, 6718 ZB Ede, The Netherlands.
Tamara DekkerAmsterdam UMC, Department of Experimental Immunology, University of Amsterdam and Amsterdam Infection & Immunity Institute, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Barbara SmidsAmsterdam UMC, Department of Experimental Immunology, University of Amsterdam and Amsterdam Infection & Immunity Institute, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Ridha KhurshidAmsterdam UMC, Department of Experimental Immunology, University of Amsterdam and Amsterdam Infection & Immunity Institute, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Wim CalameStatistiCal B.V., Strandwal 148, 2241 MN Wassenaar, The Netherlands.ORCID 0000-0002-8716-9321
Alwine KardinaalNIZO, Kernhemseweg 2, 6718 ZB Ede, The Netherlands.
René LutterAmsterdam UMC, Department of Experimental Immunology, University of Amsterdam and Amsterdam Infection & Immunity Institute, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Ruud AlbersNutriLeads B.V., Bronland 12-N, 6708 WH Wageningen, The Netherlands.
Amsterdam University Medical Centers · NLNederlands Instituut Voor Zuivel Oonderzoek · NLNutriLeads (Netherlands) · NL

Funding

European Union's Horizon 2020 research and innovation program EFRO OP-OOST 2014-2020 CHALLENGE PROJ-00676Eurostars E! 10574-NIMFSME 811592
6 · The paper itself

Abstract

An adequate and balanced supply of nutrients is essential for maintaining health, and an optimal immune response is fast, contained and properly controlled, curbing infections quickly while minimizing damage. Several micronutrients contribute to normal immune function and certain dietary fibers, for example pectic polysaccharides, can play an important role in educating and regulating immune cell responses. The aim of this paper is to elaborate on our initial findings that dietary supplementation with carrot-derived rhamnogalacturonan-I (cRG-I) accelerates and augments local innate immune and anti-viral interferon response to a rhinovirus-16 (RV16) infection and reduces the severity and duration of symptoms in humans. Dietary intake of cRG-I also enhanced immune responses to this respiratory viral infection as measured by ex vivo stimulation of whole blood with the Toll-like receptor 3 (TLR3) ligand polyinosinic:polycytidylic acid and NK cell function. Consumption of cRG-I also reduced the negative effects of this common cold infection on quality of life as assessed by individual symptom scores. RG-I from carrot is a safe, sustainable, and economically viable solution that could easily be integrated into food products and dietary supplements aiming to support immune fitness and wellbeing.

Indexed as

Daucus carotaRhinovirusDietary FiberDietary SupplementsHealthy VolunteersHumansImmunityInterferonsLigandsMicronutrientsPoly I-CQuality of LifeRhamnogalacturonansToll-Like Receptor 3Dietary FiberInterferonsLigandsMicronutrientsPoly I-CRhamnogalacturonansToll-Like Receptor 3common coldhealthy adultsinnate immuneJackson scorequality of lifeRG-Irhinovirus-16WURSS-21

Identifiers

PMID36296939
PMCPMC9607575
OpenAlexW4304775586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.